Moneycontrol PRO
Upcoming Webinar:Moneycontrol Pro in association with Quants League Sep'21 Edition brings to you to 5-Days Live Algorithmic Options Trading Virtual Conference. Register Now!

Thyrocare Tech, Dr Lal PathLabs rise 9% as govt allow private lab to do coronavirus testing

The total number of coronavirus cases in India rose to 147, with 10 fresh cases reported from various parts of the country.

March 18, 2020 / 11:27 AM IST
Representative image

Representative image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Share prices of Thyrocare Technologies and Dr Lal PathLabs rose 9 percent each intraday on March 18 after the government said it will allow private laboratories to do testing of coronavirus.

As the number of cases of coronavirus (COVID-19) disease is increasing in India, the government is exploring the possibility of allowing private laboratories to ramp up testing.

As of now, the entire testing for coronavirus infection is done by government laboratories under the Indian Council of Medical Research (ICMR). The tests are done by 52 viral research and diagnostic laboratories (VRDL) spread across India. The National Institute of Virology (NIV) at Pune - the apex laboratory - is monitoring VRDLs, marshalling resources and setting standards.

Today, one more person tested positive in Pune and with this total number of positive cases reached 18 in Pune and 42 in Maharashtra.

The total number of coronavirus cases in India rose to 147, with 10 fresh cases reported from various parts of the country.

Close
At 11:00 hrs, Dr Lal PathLabs was quoting at Rs 1,549.85, up Rs 47.55, or 3.17 percent and Thyrocare Technologies was quoting at Rs 569.50, up Rs 30.55, or 5.67 percent on the BSE.
News18
first published: Mar 18, 2020 11:24 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark